In vitro studies of temsirolimus in renal cell carcinoma cell lines showed reduction of hypoxia‐inducible factors HIF‐1 and HIF‐2 alpha, and the vascular endothelial growth factor (VEGF). The gene discussed is VEGFA; the disease is hereditary clear cell renal cell carcinoma.